Dr. Krishna Komanduri, DO

Dr. Komanduri practices at US Renal Care Pottstown Dialysis in Bethlehem, Pennsylvania.

Dr. Komanduri's NPI, 1295093466, was assigned on April 25, 2012. Dr. Komanduri holds Pennsylvania license OS018815.

Dr. Komanduri's primary practice is US Renal Care Pottstown Dialysis, at 95 Highland Ave, Bethlehem, PA 18017 in Northampton County. The practice phone is (610) 718-1127.

Dr. Komanduri's primary practice is US Renal Care Pottstown Dialysis in Bethlehem, Pennsylvania. Dr. Komanduri is also affiliated with Reading Hospital. The medical group on file is Kidney Care Specialists-Medical Associates of Drexel Hill. Dmand AI also links Dr. Komanduri to 4 more hospitals, 2 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Komanduri practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Komanduri's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Komanduri is licensed in Pennsylvania.

CMS data shows 1,487 Medicare services from Dr. Komanduri across 12 procedure codes in 2024, for 611 Medicare patients. Medicare paid $147,662 for them.

CMS counts 611 Medicare patients who saw Dr. Komanduri in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 3.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Komanduri's median patient age at 71, with 46% women.

In 2024, Dr. Komanduri wrote 1,291 Medicare Part D claims for 227 patients. 90% of them were for generic drugs. CMS names the drug for 1,085 of them, across 34 drugs with 11 or more claims each, at $318,234 in total drug cost. In 2023, CMS named 997 claims across 29 drugs.

Dr. Komanduri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Komanduri as offering telehealth.

Dmand AI links 104 papers to Dr. Komanduri, published from 2010 to 2025. 2021 was the busiest year, with 11. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Graft vs Host Disease. Dr. Komanduri has published most often in Transplant Cell Ther. Dr. Komanduri's most frequent co-authors are Krishna V. Komanduri, MD, Michele I. Morris, MD and Lazaros J. Lekakis, MD.

Dmand AI links Dr. Komanduri to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Anemia, Aplastic and Bone Marrow Failure Disorders.

CMS Open Payments shows 227 general payments to Dr. Komanduri from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Mallinckrodt LLC paid the most, $663.